Literature DB >> 11756366

Supraphysiological estradiol levels do not affect oocyte and embryo quality in oocyte donation cycles.

Joseph E Peña1, Peter L Chang, Lai-King Chan, Khaled Zeitoun, Melvin H Thornton, Mark V Sauer.   

Abstract

BACKGROUND: The study aim was to determine whether supraphysiological estradiol (E(2)) levels reduce oocyte/embryo quality in oocyte donation cycles.
METHODS: A retrospective analysis of 330 consecutive fresh oocyte donation cycles was performed in an assisted reproductive treatment programme between January 1996 and December 2000. Throughout the study period, oocyte donors and recipients followed a standard synchronization regimen that did not vary. A serum E(2) level (peak E(2)) was obtained from all oocyte donors on the morning of HCG administration. Peak E(2) values were grouped by 33rd percentile (group I, <1500 pg/ml; group II, 1500-3000 pg/ml; and group III, >3000 pg/ml). All embryo transfers were performed on day 3 after oocyte recovery.
RESULTS: Comparisons between groups revealed no significant differences in the quality of oocytes retrieved, and in fertilization rates. Higher peak E(2) levels were directly correlated with a greater number of oocytes retrieved, embryos available for transfer and cryopreservation, and higher average embryo quality scores (P < 0.005). Compared with group I, group III had significantly higher embryo implantation rates (P < 0.05).
CONCLUSIONS: Sustained supraphysiological E(2) levels do not adversely affect the quality of developing oocytes and embryos. On the contrary, elevated E(2) levels are associated with a larger number of oocytes and embryos and high-grade embryos for transfer/cryopreservation and, consequently, improved implantation rates.

Mesh:

Substances:

Year:  2002        PMID: 11756366     DOI: 10.1093/humrep/17.1.83

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  25 in total

1.  Cumulative exposure to high estradiol levels during the follicular phase of IVF cycles negatively affects implantation.

Authors:  Murat Arslan; Silvina Bocca; Ebru Ozturk Arslan; Hakan E Duran; Laurel Stadtmauer; Sergio Oehninger
Journal:  J Assist Reprod Genet       Date:  2007-02-16       Impact factor: 3.412

2.  Assessing predictors for the success of GnRH antagonist protocol in reproductive women in IVF/ICSI - in fresh cycles.

Authors:  An-Cong Wang; Ying Wang; Feng-Xia Wu; Dong-Yi Zhu
Journal:  Biomed Rep       Date:  2017-09-14

3.  Epigenetic alterations of CYP19A1 gene in Cumulus cells and its relevance to infertility in endometriosis.

Authors:  Elham Hosseini; Fereshteh Mehraein; Maryam Shahhoseini; Leili Karimian; Fatemeh Nikmard; Mahnaz Ashrafi; Parvaneh Afsharian; Reza Aflatoonian
Journal:  J Assist Reprod Genet       Date:  2016-05-11       Impact factor: 3.412

4.  Serum estradiol as a predictor of success of in vitro fertilization.

Authors:  Suneeta Mittal; Prerna Gupta; Neena Malhotra; Neeta Singh
Journal:  J Obstet Gynaecol India       Date:  2013-11-01

5.  Serum estradiol:oocyte ratio as a predictor of reproductive outcome: an analysis of data from >9000 IVF cycles in the Republic of Ireland.

Authors:  Denis A Vaughan; Conor Harrity; E Scott Sills; Edgar V Mocanu
Journal:  J Assist Reprod Genet       Date:  2016-02-06       Impact factor: 3.412

6.  Is the probability of pregnancy after ovarian stimulation for IVF associated with serum estradiol levels on the day of triggering final oocyte maturation with hCG? A systematic review and meta-analysis.

Authors:  Glykeria I Karatasiou; J K Bosdou; C A Venetis; L Zepiridis; K Chatzimeletiou; T B Tarlatzi; G Lainas; B C Tarlatzis; G Grimbizis; E M Kolibianakis
Journal:  J Assist Reprod Genet       Date:  2020-05-29       Impact factor: 3.412

7.  Effect of estradiol on oocyte development.

Authors:  Katherine Bianco; Neal G Mahutte; Aydin Arici; Denny Sakkas; Hugh S Taylor
Journal:  Int J Gynaecol Obstet       Date:  2008-12-03       Impact factor: 3.561

8.  Use of stimulated serum estradiol measurements for the prediction of hyperresponse to ovarian stimulation in in vitro fertilization (IVF).

Authors:  D J Hendriks; E R Klinkert; L F J M M Bancsi; C W N Looman; J D F Habbema; E R te Velde; F J Broekmans
Journal:  J Assist Reprod Genet       Date:  2004-03       Impact factor: 3.412

9.  Oocyte and embryo quality in patients with excessive ovarian response during in vitro fertilization treatment.

Authors:  Ernest Hung Yu Ng; Estella Yee Lan Lau; William Shu Biu Yeung; Pak Chung Ho
Journal:  J Assist Reprod Genet       Date:  2003-05       Impact factor: 3.412

Review 10.  Preserving female fertility following cancer treatment: current options and future possibilities.

Authors:  Erin R West; Mary B Zelinski; Laxmi A Kondapalli; Clarisa Gracia; Jeffrey Chang; Christos Coutifaris; John Critser; Richard L Stouffer; Lonnie D Shea; Teresa K Woodruff
Journal:  Pediatr Blood Cancer       Date:  2009-08       Impact factor: 3.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.